Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZA-PD trial of azathioprine in Parkinson's disease
2018-003089-14Phase 2Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Azathioprine with Placebo (2 arms). Primary endpoint: Change in MDS-UPDRS gait/axial score in the OFF state over 12 months. Status: unknown.
02
Drugs
azathioprine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2018-003089-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003089-14.